The American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all health care providers working in the fields of tropical medicine, hygiene and global health.
You can find DNDi at Booth #410!
Symposia
New tools to accelerate elimination of onchocerciasis
Date: Sunday, 24 November 2019
Time: 8:00-9:45
Room: National Harbor 11 (National Harbor Level)
Co-chairs: Sara Lustigman, Head of Molecular Parasitology Lab, NY Blood Center, USA and Annie Mo, NIAID, NIH, USA
| Accelerating elimination of NTDs in AFRICA: Onchocerciasis Maria Rebollo Polo, Head of ESPEN, WHO Africa, DRC |
| Macrofilaricidal drug development – onwards and upwards Sabine Specht, Head Filarial Diseases, DNDi, Switzerland |
| Prophylactic vaccine and vaccine linked-chemotherapy to protect against new infections Sara Lustigman, Head of Molecular Parasitology Lab, NY Blood Center, USA |
| Biomarkers for infections and success of elimination Tom Nutman, NIAID, NIH, USA |
| Overview of resources available for transnational research Annie Mo, NIAID, NIH, USA |
Exploring the range of clinical efforts to identify repurposed drugs for neglected infectious diseases
Date: Sunday, 24 November 2019
Time: 11:15-13:00
Room: Maryland B (Ballroom Level)
Chair: Parvesh Paul, NCATS/NIH, Rockville, MD, United States
| CURE ID: A mobile app for capturing case reports directly from clinicians globally of repurposed drugs for infectious diseases Parvesh Paul, NCATS/NIH, Rockville, MD, United States |
| Cures within reach – Small scale clinical trials of repurposed drugs in developing countries Clare Thibodeaux, Cures Within Reach, Chicago, IL, United States |
| DNDi: Clinical trials of repurposed drugs in novel combinations, doses and routes, and identification of new compounds Nathalie Strub-Wourgaft, NTD Director, DNDi, Switzerland |
| Meta-analyses of individual patient data from clinical trials Philippe J. Guerin, University of Oxford, Oxford, United Kingdom |
Oral presentations
Date: Thursday, 21 November 2019
Time: 13:45-14:00
Room: National Harbor 11 (National Harbor Level)
| The burden of lymphatic filariasis in Africa for 2000, 2020 and 2025 Vinkeles Melchers NV*, Stolk WA , Pedrique B , Vanhommerig JW, Coffeng LE , de Vlas SJ |
Date: Friday, 22 November 2019
Time: 14:15-14:30
Room: National Harbor 11 (National Harbor Level)
| Drug development for the treatment and control of onchocerciasis: A population pharmacokinetic analysis of emodepside (BAY 44-4400) in healthy volunteers Assmus F*, Hoglund RM, Scandale I, Tarning J |
Date: Friday, 22 November 2019
Time: 16:00-16:15
Room: National Harbor 2 (National Harbor Level)
| Estimation of incidence rate of mortality for antileishmanial therapies: A systematic review of published literature from 1980 to 2018 Singh S*, Dahal P, Ngu R, Maguire B, Olliaro P, Stepniewska K, Halleux C, Alves F |
Posters
Date: Saturday, 23 November 2019
Time: 12:00-13:45
Room: Prince George’s Exhibit Hall D (Lower Atrium Level)
| Evaluating new regimens for the treatment of chronic Chagas disease: The BENDITA trial Barreira F, Blum B, Garcia W, Gascón J, Ortiz L, Torrico F, Sosa-Estani S |
| Comparative evaluation of conventional, quantitative and droplet digital PCR for the molecular diagnosis of Chagas disease Nath-Chowdhury M, Ndao M, Chatelain E, Strong C, Scott-Lourenço M |
More information:
